Our Story
Dr. Alya El Hedda, a graduate of the Faculty of Pharmacy of Paris XI in Chatenay Malabry, embodies boldness and a vision for positive change in the pharmaceutical sector in Tunisia.
Founder of OPALIA Pharma, she has always aimed to make advanced therapies accessible to all, while adhering to the highest international standards.
Since its creation in 1988, OPALIA Pharma has distinguished itself as a pioneer in the manufacturing of generic medicines in Tunisia, even paving the way for the African market in 1995. OPALIA’s ethical and scientific reputation, along with its proven expertise, attracted the attention of foreign investors, leading to the acquisition of 90% of the company’s shares by the RECORDATI Group in 2013.
Dr. Alya El Hedda has guided her teams by cultivating values of ethics, transparency, and social and environmental commitment throughout her journey. Her inspiring leadership, which places the patient and their environment at the heart of her concerns, has made her one of the most inspiring figures in the Tunisian pharmaceutical industry. Her exceptional career reflects her ability to create lasting value and have a positive impact on future generations.
At Opalia Recordati, we are committed to improving the health and quality of life of patients by ensuring accessible, high-quality treatments that comply with the strictest international standards. With our expertise and dedication to innovation, we place ethics, integrity, and social responsibility at the heart of our actions. As a key player in the pharmaceutical sector, we foster a collaborative and dynamic environment where every talent can thrive and unleash its full potential.
Improving the health and quality of life of patients while staying true to our values of ethics, integrity, and social and societal responsibility by ensuring accessible, high-quality treatments in accordance with the strictest international standards.
Today, nearly 35 years later, Dr. Alya El Hedda’s commitment and determination continue. Opalia Recordati is now part of the global pharmaceutical group, Recordati, listed on the Milan Stock Exchange, with over 4,350 employees.
Making Opalia Recordati “The Best Place to Be” by fostering a dynamic, collaborative, and enriching work environment.
We are committed to providing all the necessary resources for each team member to unleash their full potential, thereby promoting both their professional and personal growth.
Every day, in every way, we do everything possible so that people can live full lives – we do this together, working closely with suppliers, partners and doctors from Brazil to the Far East, in around 150 countries. We will always continue to build with our people, planet, community, and our own roots, at our heart.
Underpinned by a history of strong financial delivery, we will continue to grow from within, capture opportunities within our own pipeline, and identify opportunities to bring in new treatments through partnerships & acquisitions across all our businesses.
MILESTONES
Dr. Alya El Hedda founded OPALIA Pharma, the first private Tunisian pharmaceutical company.
First marketing authorization.
Start of local production.
First exports to Iraq and Libya.
Strengthening of production capacity.
Export to French-speaking West African countries.
Establishment of the new production site.
Production site approved for the GCC and UAE.
Acquisition of Opalia Pharma by the Recordati Group